histamine has been researched along with Triple Negative Breast Neoplasms in 2 studies
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts." | 7.96 | Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020) |
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts." | 3.96 | Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Nicoud, MB | 2 |
Ospital, IA | 1 |
Táquez Delgado, MA | 2 |
Riedel, J | 1 |
Fuentes, P | 1 |
Bernabeu, E | 1 |
Rubinstein, MR | 1 |
Lauretta, P | 1 |
Martínez Vivot, R | 1 |
Aguilar, MLÁ | 1 |
Salgueiro, MJ | 1 |
Speisky, D | 1 |
Moretton, MA | 1 |
Chiappetta, DA | 1 |
Medina, VA | 2 |
Sterle, HA | 1 |
Massari, NA | 1 |
Formoso, K | 1 |
Herrero Ducloux, MV | 1 |
Martinel Lamas, D | 1 |
Cremaschi, GA | 1 |
2 other studies available for histamine and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Carriers; Histamine; Humans; Mice | 2023 |
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Databases | 2020 |